CZ100494A3 - Process and composition for determining immunobiological activity of biologically active cytokin-inducing immunomodulator substances - Google Patents

Process and composition for determining immunobiological activity of biologically active cytokin-inducing immunomodulator substances Download PDF

Info

Publication number
CZ100494A3
CZ100494A3 CZ941004A CZ100494A CZ100494A3 CZ 100494 A3 CZ100494 A3 CZ 100494A3 CZ 941004 A CZ941004 A CZ 941004A CZ 100494 A CZ100494 A CZ 100494A CZ 100494 A3 CZ100494 A3 CZ 100494A3
Authority
CZ
Czechia
Prior art keywords
ttp
substance
pbl
cytokine
culture
Prior art date
Application number
CZ941004A
Other languages
Czech (cs)
English (en)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of CZ100494A3 publication Critical patent/CZ100494A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CZ941004A 1991-10-26 1992-09-28 Process and composition for determining immunobiological activity of biologically active cytokin-inducing immunomodulator substances CZ100494A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances

Publications (1)

Publication Number Publication Date
CZ100494A3 true CZ100494A3 (en) 1994-11-16

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ941004A CZ100494A3 (en) 1991-10-26 1992-09-28 Process and composition for determining immunobiological activity of biologically active cytokin-inducing immunomodulator substances

Country Status (22)

Country Link
US (1) US5543300A (2)
EP (2) EP0539610A1 (2)
JP (1) JPH07500905A (2)
AT (1) ATE153763T1 (2)
AU (1) AU678343B2 (2)
BG (1) BG61705B1 (2)
CA (1) CA2122131A1 (2)
CZ (1) CZ100494A3 (2)
DE (3) DE539610T1 (2)
DK (1) DK0609255T3 (2)
ES (1) ES2061424T3 (2)
FI (1) FI941920L (2)
GR (3) GR930300100T1 (2)
HU (1) HU216863B (2)
LV (1) LV12140B (2)
NO (1) NO941444L (2)
PL (1) PL170592B1 (2)
RO (1) RO114837B1 (2)
RU (1) RU2125727C1 (2)
SG (1) SG72665A1 (2)
SK (1) SK44094A3 (2)
WO (1) WO1993008470A1 (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
AU5643299A (en) * 1998-09-23 2000-04-10 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DK1449535T3 (da) * 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
AU2012304640A1 (en) 2011-09-07 2014-03-13 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
DE529032T1 (de) * 1991-03-16 1993-11-25 Torf Ets Verfahren zur extraction von torf und apparat zur durchführung dieses verfahrens.

Also Published As

Publication number Publication date
RU94022481A (ru) 1996-09-27
DE69220078D1 (de) 1997-07-03
GR3024457T3 (en) 1997-11-28
NO941444D0 (no) 1994-04-21
FI941920A7 (fi) 1994-04-25
FI941920A0 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
EP0609255A1 (en) 1994-08-10
PL170592B1 (en) 1997-01-31
FI941920L (fi) 1994-04-25
HU9401185D0 (en) 1994-07-28
SK44094A3 (en) 1995-03-08
BG98720A (bg) 1995-07-28
HU216863B (hu) 1999-09-28
BG61705B1 (bg) 1998-03-31
RO114837B1 (ro) 1999-07-30
LV12140A (lv) 1998-09-20
ES2061424T1 (es) 1994-12-16
HK1002610A1 (en) 1998-09-04
GR940300077T1 (en) 1994-11-30
EP0539610A1 (en) 1993-05-05
WO1993008470A1 (en) 1993-04-29
DE539610T1 (de) 1993-12-16
HUT69990A (en) 1995-09-28
US5543300A (en) 1996-08-06
DK0609255T3 (da) 1997-12-22
CA2122131A1 (en) 1993-04-29
GR930300100T1 (2) 1993-10-29
AU2650992A (en) 1993-05-21
DE609255T1 (de) 1995-06-14
JPH07500905A (ja) 1995-01-26
AU678343B2 (en) 1997-05-29
SG72665A1 (en) 2000-05-23
LV12140B (lv) 1998-12-20
ES2061424T3 (es) 1997-10-01
ATE153763T1 (de) 1997-06-15
EP0609255B1 (en) 1997-05-28
NO941444L (no) 1994-06-16
RU2125727C1 (ru) 1999-01-27

Similar Documents

Publication Publication Date Title
RU2518341C2 (ru) Иммунные модуляторы, препараты и композиции, содержащие иммунные модуляторы, тесты для оценки активности иммунных модуляторов и препаратов, и композиций, содержащих их, и способы
Nahmias et al. Inhibitory effect of heparin on herpes simplex virus
Gallin et al. Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink, and cattle
CZ100494A3 (en) Process and composition for determining immunobiological activity of biologically active cytokin-inducing immunomodulator substances
Koff et al. Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells.
Ahmed-Choudhury et al. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2
EP0198061A1 (en) Use of compositions comprising sulfosuccinates for the manufacture of a medicament for preventing or treating viral infections
Kim et al. Taraxacum officinale restores inhibition of nitric oxide production by cadmium in mouse peritoneal macrophages
Pruett et al. Immunotoxicological characteristics of sodium methyldithiocarbamate
Turco et al. Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines
Rinehart et al. Phase I/II trial of interferon-β-serine in patients with renal cell carcinoma; immunological and biological effects
JPH01110633A (ja) 肝細胞刺激因子
ME00530B (me) Farmaceutske kompozicije tizoksanida i nitazoksanida
Kim et al. Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages
Kim et al. The immunomodulatory effects of the herbicide simazine on murine macrophage functions in vitro
Scott et al. Tolerance of one‐month intranasal interferon
Iliakis et al. Reduction by caffeine of adriamycin-induced cell killing and DNA damage in Chinese hamster cells: correlation with modulation in intracellular adriamycin content
Castronuovo Jr et al. Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon
HK1002610B (en) Method and composition for determining the immunological activity of bioactive substances
Rożynkowa et al. Destructive effect of methyl mercury chloride on human mitoses in living cells in vitro
Farrow et al. Nephrotic syndrome in the cat due to diffuse membranous glomerulonephritis
Hamburger et al. Cytotoxicity of human β-interferon for differentiating leukemic HL-60 cells
Pearson et al. TGF‐β is not the principal immunosuppressive component in coagulation factor concentrates
Hayashi et al. Decrease in neutrophil migration induced by endotoxin and suppression of interleukin-1 production by macrophages in lactic dehydrogenase virus-infected mice
Watts et al. Effects of chlorhexidine solution on neutrophil locomotion in vitro

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic